13F

Stock

Theravance Biopharma, Inc.

TBPH · held by 1 managers

Reported value

$464.7K

Holders

1

+0 new · −0 exited

Holders’ est. mark

−$25K

Price effect on 1 books still in the name

Largest holder

$464.7K

BARCLAYS PLC

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
BARCLAYS PLC52K$464.7K−$25KCut−$239.1K

Positions as of Q1 2025. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.